SHORT-COURSE CHEMOTHERAPY OF PULMONARY TUBERCULOSIS WITH A FIXED COMBINATION OF ISONIAZID, RIFAMPICIN AND PYRAZINAMIDE (RIFATER) - FINAL RESULTS AFTER 2 YEARS

被引:0
作者
BRANDLI, O
HAEGI, V
VILLIGER, B
BOHN, W
BAUMANN, HR
ZACH, R
机构
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:299 / 305
页数:7
相关论文
共 50 条
[41]   SHORT-COURSE CHEMOTHERAPY FOR PULMONARY TUBERCULOSIS - A 100-DAY INTERRUPTED REGIMEN [J].
ESCREET, BC ;
COWIE, RL .
SOUTH AFRICAN MEDICAL JOURNAL, 1981, 60 (25) :951-955
[42]   CONTROLLED CLINICAL-TRIAL OF LEVAMISOLE IN SHORT-COURSE CHEMOTHERAPY FOR PULMONARY TUBERCULOSIS [J].
DARBYSHIRE, JH .
AMERICAN REVIEW OF RESPIRATORY DISEASE, 1989, 140 (04) :990-995
[43]   HONG-KONG-TUBERCULOSIS-TREATMENT-SERVICES-BRITISH-MEDICAL-RESEARCH COUNCIL STUDY OF SHORT-COURSE REGIMENS OF STREPTOMYCIN, ISONIAZID AND PYRAZINAMIDE - LATEST RESULTS [J].
GIRLING, DJ .
SCANDINAVIAN JOURNAL OF RESPIRATORY DISEASES, 1975, :5-5
[44]   SHORT-COURSE CHEMOTHERAPY FOR TUBERCULOUS PLEURAL EFFUSION AND CULTURE-NEGATIVE PULMONARY TUBERCULOSIS [J].
ORMEROD, LP ;
MCCARTHY, OR ;
RUDD, RM ;
HORSFIELD, N .
TUBERCLE AND LUNG DISEASE, 1995, 76 (01) :25-27
[45]   SHORT-COURSE CHEMOTHERAPY FOR 6 MONTHS IN SMEAR-NEGATIVE PULMONARY AND PLEURAL TUBERCULOSIS [J].
DUTT, AK ;
MOERS, D ;
THOMAS, C ;
STEAD, WW .
AMERICAN REVIEW OF RESPIRATORY DISEASE, 1983, 127 (04) :192-192
[46]   SHORT-COURSE CHEMOTHERAPY FOR PLEURAL TUBERCULOSIS - 9 YEARS EXPERIENCE IN ROUTINE TREATMENT SERVICE [J].
DUTT, AK ;
MOERS, D ;
STEAD, WW .
CHEST, 1986, 90 (01) :112-116
[47]   INFLUENCE OF INITIAL-DRUG RESISTANCE ON THE RESPONSE TO SHORT-COURSE CHEMOTHERAPY OF PULMONARY TUBERCULOSIS [J].
MITCHISON, DA ;
NUNN, AJ .
AMERICAN REVIEW OF RESPIRATORY DISEASE, 1986, 133 (03) :423-430
[49]   CONTROLLED TRIAL OF SHORT-COURSE REGIMENS OF CHEMOTHERAPY IN THE AMBULATORY TREATMENT OF SPINAL TUBERCULOSIS - RESULTS AT 3 YEARS OF A STUDY IN KOREA [J].
DARBYSHIRE, J .
JOURNAL OF BONE AND JOINT SURGERY-BRITISH VOLUME, 1993, 75 (02) :240-248
[50]   Short-course rifampin and pyrazinamide compared with isoniazid for latent tuberculosis infection: A cost-effectiveness analysis based on a multicenter clinical trial [J].
Jasmer, RM ;
Snyder, DC ;
Saukkonen, JJ ;
Hopewell, PC ;
Bernardo, J ;
King, MD ;
Kawamura, LM ;
Daley, CL .
CLINICAL INFECTIOUS DISEASES, 2004, 38 (03) :363-369